Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011
Mon, December 26, 2011
Fri, December 23, 2011
Thu, December 22, 2011
Wed, December 21, 2011
Tue, December 20, 2011
[ Tue, Dec 20th 2011 ] - Market Wire
Bard Acquires Lutonix, Inc.

Medivation Announces Participation at Upcoming Investor Conference


//health-fitness.news-articles.net/content/2011/ .. rticipation-at-upcoming-investor-conference.html
Published in Health and Fitness on Monday, December 26th 2011 at 13:15 GMT by Market Wire   Print publication without navigation


December 26, 2011 16:10 ET

Medivation Announces Participation at Upcoming Investor Conference

SAN FRANCISCO, CA--(Marketwire - Dec 26, 2011) - Medivation, Inc. (NASDAQ: [ MDVN ]) today announced that David Hung, M.D., president and chief executive officer, will present at the following investor conference:

  • The JP Morgan 30th Annual Healthcare Conference on January 10 at 3:00pm Pacific Time at the Westin St. Francis in San Francisco.

Dr. Hung will provide an overview of Medivation and its clinical development programs.

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. Together with its corporate partners Astellas and Pfizer, Medivation currently has investigational drugs in Phase 3 development to treat advanced prostate cancer and mild-to-moderate Alzheimer's disease. For more information, please visit us at [ www.medivation.com ].



Publication Contributing Sources